HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.

Lavinia FabeniDaniele ArmeniaIsabella AbbateRoberta GagliardiniValentina MazzottaAda BertoliWilliam GennariFederica ForbiciGiulia BernoLorenzo PiermatteoVanni BorghiCarmela PinnettiAlessandra VergoriAnnalisa MondiGiustino ParrutiFiorella Di SoraMarco IannettaMiriam LichtnerAlessandra LatiniCristina MussiniLoredana SarmatiCarlo Federico PernoEnrico GirardiAndrea AntinoriFrancesca Ceccherini-SilbersteinFabrizio MaggiMaria Mercedes Santoronull null

Published in: The Journal of antimicrobial chemotherapy (2024)

Between 2015 and 2021, TDR prevalence in Italy was 8% and remained almost stable over time. Resistant strains were found circulating regardless of being in TCs, but less likely in non-B subtypes. These results highlight the importance of a continuous surveillance of newly diagnosed individuals for evidence of TDR to inform clinical practice.

Keyphrases

newly diagnosed
clinical practice
antiretroviral therapy
hiv positive
hiv infected
human immunodeficiency virus
public health
escherichia coli
hepatitis c virus
hiv testing
risk factors
hiv aids
south africa